Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA

Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA

283620

Imagio Imaging System for Breast Cancer Diagnosis Approved by FDA

Imagio, Seno Medical Instruments’ non-invasive and radiation-free breast imaging technology, has been approved for commercialization by the Center for Devices and Radiological Health, part of the U.S. Food and Drug Administration (FDA). The technology — known fully as the Imagio Breast Imaging System — was designed to help physicians better distinguish malignant, or cancerous breast tumors from benign ones. “We are thrilled to have reached this milestone and are looking forward to moving our technology platform…

You must be logged in to read/download the full post.